Shigeki Fukuzawa
Papers
2
Total Citations
9
H-Index
2
About
Shigeki Fukuzawa is a leading urologic surgeon and researcher whose work focuses on optimizing surgical outcomes in robot-assisted radical prostatectomy, particularly for high-risk prostate cancer. His research addresses critical questions in perioperative management and oncologic control, with a special emphasis on balancing cancer eradication with functional preservation. In a landmark 2024 study (7 citations), Fukuzawa systematically evaluated the effects of thienopyridine-class antiplatelet agents—including ticlopidine, clopidogrel, and prasugrel—on bleeding complications following robot-assisted radical prostatectomy, providing crucial evidence for managing patients on these medications. His equally important 2024 investigation (2 citations) examined the impact of neurovascular bundle preservation on biochemical recurrence in high-risk prostate cancer, challenging conventional wisdom by demonstrating that nerve-sparing techniques may not compromise oncologic outcomes in carefully selected patients. These contributions have direct clinical implications, helping surgeons refine patient selection and surgical technique. Fukuzawa’s work exemplifies the modern trend toward evidence-based, personalized surgical care, where large database analyses guide nuanced decision-making at the intersection of cancer control and quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2